Background-We investigated the possibility that a frequent trigger action might play a role in the development of persistent atrial fibrillation (PeAF) and the presence of a substrate. Methods and Results-In 263 consecutive patients who underwent catheter ablation (CA) for PeAF, electric cardioversion was performed at the beginning of the procedure to determine the presence or absence of an immediate recurrence of AF (IRAF). We defined an IRAF as a reproducible AF recurrence within 90 s after restoration of sinus rhythm by electric cardioversion. We performed a meanϮSD of 1.3Ϯ0.5 sessions of CA, including pulmonary vein isolation and ablation of the premature atrial contractions that triggered the IRAF (IRAF triggers), and observed the patients for 17 (10 -27) months. An IRAF was observed in 70 patients (27%), but we could not ablate the IRAF triggers in 16 (23%) of these IRAF patients. The recurrence rate of PeAF was higher in patients with an unsuccessful IRAF trigger ablation than in those with successful IRAF trigger ablation (63% versus 11%; PϽ0.001). A multivariable analysis also revealed that an unsuccessful IRAF trigger ablation was 1 of the independent predictors of recurrent PeAF (odds ratio, 10.9; 95% CI, 3.4 -36.7). Conclusions-In the PeAF patients with an IRAF, successful elimination of the IRAF triggers, in addition to pulmonary vein isolation, resulted in a successful CA. These results imply that such triggers play a major role in the AF persistence in these PeAF patients. (Circ Arrhythm Electrophysiol. 2012;5:295-301.)
T he mechanism of atrial fibrillation (AF) is not fully understood. The factors associated with the mechanism of AF fall into 3 categories: the trigger factors, the arrhythmogenic substrate, and the modulating factors, such as the autonomic nervous system, ischemia, and hormones. This is the concept of Coumel triangle of arrhythmogenesis. It is generally thought that the triggers initiate AF and that the substrate determines its persistence; in addition, the substrate plays the critical role in the mechanism of AF persistence. Intensive catheter ablation (CA) of substrates in the left atrium (LA), such as defragmentation and linear lesions, was applied in the patients with persistent/longlasting persistent AF (PeAF). [1] [2] [3] However, the pathophysiological characteristics of AF persistence are not uniform, and we suspect that there may be a trigger-based mechanism of AF persistence in some of the PeAF patients ( Figure 1 ). If the patients in this model received cardioversion by direct current, they would not be able to maintain sinus rhythm (SR) because of the frequent generation of AF. On the other hand, there is a phenomenon called immediate recurrence of AF (IRAF), which is a reproducible recurrence of AF immediately after electric cardioversion and restoration of SR 4, 5 (Figure 2 ). We hypothesized that the PeAF patients with an IRAF phenomenon had a trigger-based mechanism of AF persistence and that the premature atrial contractions (PACs) triggering IRAFs (IRAF triggers) played an important role in the mechanism of AF persistence ( Figure 2 ), and the elimination of such triggers would have a great impact on the results of the CA.
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Methods
Study Population
The study population consisted of 263 consecutive patients who underwent first-time CA of PeAF, including 131 long-lasting persistent AF patients (AF persisting Ͼ1 year), from January 2007 to December 2009 at our institution. The definition of PeAF was AF that persisted for Ͼ1
week. The patients who previously received CA or underwent a Maze operation were excluded. All antiarrhythmic drugs were discontinued 3 to 5 half-lives before the CA. In those patients receiving amiodarone, this drug was discontinued at least 2 months before the ablation. The sustained AF duration was defined as the longest-lasting AF episode assessed from the medical records and Holter electrocardiogram, and patient complaints if the episodes were symptomatic in the clinical setting. All patients underwent transesophageal echocardiography within 24 hours before the procedure, and those who had any left atrial thrombi were excluded. We performed cardiac computed tomography before the CA procedure to determine the shape of the pulmonary veins (PVs) and LA and to measure the LA volume. All patients provided written informed consent for the electrophysiological study and CA. This study was approved by our institutional review board.
Electrophysiological Study
A 10-or 20-pole diagnostic catheter was positioned in the coronary sinus (CS) for pacing and recording. A 20-pole catheter was placed in the right atrium or superior vena cava (SVC). The LA and PV were accessed by a transseptal approach. We introduced 3 steerable catheters, including 2 spiral curve catheters, into the LA through a single transseptal puncture site. The PVs were mapped with a circumferential 10-or 20-pole catheter (IBI; Irvine, CA). The surface ECG and intracardiac electrograms filtered between 30 and 500 Hz were recorded simultaneously with a polygraph (DUO EP Laboratory, Bard Electrophysiology; Lowell, MA). A single 150-IU/kg bolus of heparin was administered after the transseptal puncture and repeated to maintain an activated clotting time of Ͼ300 s. The AF cycle length was manually measured in the CS and the high right atrium before electric cardioversion by averaging 30 consecutive cycles. 6 IRAFs were defined as reproducible AF recurrences within 90 s after the restoration of SR. 7 We performed electric cardioversion at the beginning of the procedure and observed for the presence or absence of an IRAF under sedation by thiamylal sodium. In the cases that SR was maintained, isoproterenol was administered initially at 1 to 2 g/minute without additional sedation, and then the dose was gradually increased to a maximum of 20 g/minute while monitoring the blood pressure carefully. If the blood pressure decreased to Ͻ70 mm Hg, the increased dose of isoproterenol was reversed to a 1-g/minute basal level. The administration of isoproterenol was performed for Ͼ5 minutes. If AF was induced, electric cardioversion was performed again and we checked for the presence or absence of IRAFs. The same protocol for the IRAF detection was adopted when the CA was repeated in a second procedure. If patients did not exhibit any IRAFs in the first session but exhibited an IRAF in the second session, we determined that they had an IRAF.
We defined an IRAF trigger as an arrhythmogenic focus causing an initiation of IRAFs at least 2 times with the same intracardiac activation sequence, and we attempted to detect the origin of an IRAF trigger in patients with an IRAF. To detect the location of the IRAF triggers, we simultaneously used 5 multipolar catheters to record the electrograms from the PVs and outside the PVs to search for any arrhythmogenic foci. A 20-pole catheter (2-mm interelectrode spacing) was placed along the area from the SVC, down the lateral wall of the right atrium. Another 10-or 20-pole catheter was inserted into the CS. Two circular catheters were located at the ostia of the left PVs. A roving catheter was located at the right superior PV ostium. If the PACs initiating an IRAF were suspected to have originated from a non-PV area uncovered by the catheters, we repeated the cardioversion, changing the location of the catheters, and attempted to search for the focus by mapping with them as described in the previously reported mapping technique. 8
Ablation Procedure
We performed an ablation procedure after the electrophysiological study. The PV isolation procedure was performed using an ipsilateral double-circular mapping catheter technique guided by fluoroscopy and angiography. We confirmed the success of the electric PV isolation by monitoring the circumferential electric isolation at the antrum level. The complete disappearance of the potentials from all 4 PVs was confirmed in all patients. A routine roof line ablation in the LA was created in 148 patients who underwent the procedure from January 2007 to October 2008. We attempted to eliminate PACs initiating AF from PV and non-PV sources. If such triggers originated from the SVC, SVC isolation was performed. Then, induction of AF was attempted by burst pacing from the CS at a cycle length of 250 ms, with a sequential decrement down to the refractory effective period or to 150 ms for 5 to 10 s and then repeated from the right atrium. If AF was inducible by burst pacing, or not all the IRAF triggers could be eliminated, substrate modification of the LA, such as an additional LA linear ablation, or ablation of any complex fractionated electric activity, was performed. If atrial tachycardia was induced, block lines across an isthmus of the induced atrial tachycardia were created. Radiofrequency energy was delivered for 20 to 40 s at each site using an 8-mm-tip catheter. The radiofrequency energy was delivered with the power limited to 35 W. The temperature was limited to 50°C (Japan Life Line Co, Ltd, Fantasista; Tokyo, Japan). The end point of the procedure was the noninducibility of AF/atrial tachycardia by burst pacing, AF termination during substrate modification, or the elimination of all complex fractionated electrocardiogram. The meanϮSD procedure time was 2.6Ϯ0.6 hours.
Patient Follow-Up
All patients were discharged to home on a meanϮSD of 3Ϯ1 days after the CA procedure and were seen in our hospital at 1-to 2-month intervals. The AF episodes after discharge were assessed by the patients' complaints, 12-lead ECG, and 24-hour Holter ECG recordings. The patients with AF recurrences underwent a second procedure. After the CA, antiarrhythmic drugs (usually a class I agent or bepridil) were given for Ͼ3 months to patients in whom residual AF was inducible. Patients were scheduled to visit our hospital at 1-month intervals for 6 months and then at a 3-month interval thereafter. We checked the ECG of the last visit to determine the Figure 1 . Hypothesis of the trigger-based mechanism of atrial fibrillation (AF) persistence and immediate recurrence of AF (IRAF). A, The mechanism of paroxysmal AF. B, The mechanism of substrate-based AF persistence. C, Schema of our hypothesis of the trigger-based mechanism of AF persistence. D, Possible mechanism causing IRAFs in the persistent AF patients with a trigger-based mechanism.
Figure 2.
An example of an immediate recurrence of atrial fibrillation (IRAF). The ECG exhibits an IRAF initiated by an ectopic beat from the left inferior pulmonary vein (LIPV) after the restoration of sinus rhythm (SR) by cardioversion. Two 20-and 10-pole spiral catheters were located in both the left superior pulmonary vein (LSPV) and LIPV. The coronary sinus (CS) and superior vena cava-right atrium (SVC-RA) were covered by a 20-pole catheter. A 4-pole roving catheter was positioned at the right superior pulmonary vein (RSPV). Cardioversion was performed successfully, and SR was restored. However, only 13 s later, AF relapsed (A). The trigger originated from the LIPV (B). We performed the cardioversion again, but the AF recurred 21 s later (C). The trigger also initiated from the LIPV (D). Then, PV isolation was performed. AF continues after PV isolation. PV firings occurred from the LPV 30 s after PV isolation (E). If the PVs were not isolated, it seemed possible that "new AF" would be generated at that time. Thus, in this patient, new AF seems to occur every 10 to 30 s and, as a result, the AF might persist.
presence or absence of PeAF recurrence in June 2010. The median (interquartile range) of the follow-up period was 17 (10 -27) months.
In this study, we investigated the incidence of the recurrence of PeAF and the factors associated with the recurrence. A recurrence of PeAF was defined as PeAF confirmed by the 12-lead ECG at the most recent hospital visit.
Statistical Analysis
The continuous variables with a normal distribution were expressed as the meanϮSD, and the data were compared by an unpaired t test between the patient groups. When the samples had an unequal variance, a Welch t test was used to compare them. The variables without a normal distribution (AF period, sustained AF period, and brain natriuretic peptide) were expressed as the median (25 th -75 th percentile), and the data were compared by a Mann-Whitney test, which was used for the nonparametric analyses. All the comparison of categorical variables was accomplished using a Fisher exact test. Multivariable logistic regression analyses were used to determine the clinical factors that were independently associated with a recurrence of AF. Binary variables with PՅ0.05 from the univariate model were included in the multivariable analysis, and excluded variables that are no longer significant at the Pϭ0.05 level were included in the multivariable model. All analyses were conducted using Stat View 5.0 software (SAS Institute; Cary, NC).
Results
Patient Characteristics and the Prevalence of an IRAF
We included 263 consecutive patients who received first-time CA of PeAF in this study. The age was 60.1Ϯ11 years. Males occupied 83% of the study population. The median AF duration was 31 months, and the median duration of persistent AF was 11 months; 131 patients (50%) had long-standing persistent AF (AF persisting for Ͼ1 year). Coexisting heart disease was found in 39% of the patients. The LA volume was 92.7Ϯ34.1 mm. A total of 189 patients subsequently had ablation other than PV isolation and AF trigger ablation.
An IRAF was observed in 70 patients (27%). IRAF triggers from the PVs were observed in 57 patients (22%), and those from non-PV sources were recorded in 23 patients (9%). Eighteen patients (7%) had multiple IRAF triggers, and 10 patients (4%) had both PV and non-PV sources. We tried to eliminate all the IRAF triggers in 70 patients with an IRAF, but 16 patients (23%) had some residual effect because of the unsuccessful mapping and ablation of such triggers.
Patient Background Related to the IRAF
We then investigated the factors associated with the IRAF. The prevalence of hypertension was significantly higher in the patients with an IRAF than in those without an IRAF (69% versus 58%; Pϭ0.04). There were no significant differences in the age, sex, presence of structural heart disease, presence of congestive heart failure, period of AF persistence, proportion of long-standing PeAF, LA volume, left ventricular ejection fraction, renal function (estimated glomerular filtration rate), serum brain natriuretic peptide level, or AF cycle length.
Efficacy of the Ablation and Factors Associated With Recurrence of PeAF
A meanϮSD of 1.31Ϯ0.49 sessions of CA were performed, and 101 patients (38%) were administered antiarrhythmic drugs at hospital discharge. Finally, of the 263 patients, 27 (10%) had recurrent PeAF at the most recent hospital visit, although at least another 41 patients (16%) had paroxysmal arrhythmia attacks and 73 patients (28%) were still receiving antiarrhythmic drugs. The patients with PeAF recurrences had a longer sustained AF duration (median, 9 versus 48 months; PϽ0.001) and a larger LA volume (90.7Ϯ33.8 versus 111Ϯ32.2 mL; Pϭ0.033). AF induction by atrial burst pacing was performed in 232 patients, and more patients in the recurrent PeAF group had residual inducibility of AF at the end of the procedure (74% versus 41%; Pϭ0.002). In addition to these factors, the patients with an IRAF had a higher rate of PeAF (55% versus 23%; PϽ0.001). The ablation procedure, such as the presence of additional LA linear ablation or ablation to CFAE, did not influence the recurrence of PeAF ( Table 1 ).
Elimination of the IRAF Triggers and Ablation Results
The recurrence rate in the PeAF patients was significantly higher in those with an IRAF than in those without an IRAF (21% versus 6%; PϾ0.001). In addition to PV isolation, we tried to eliminate all the IRAF triggers by CA, and we could not ablate them in 16 (23%) of the 70 patients with an IRAF. Those 16 patients received ablation to CFAE more frequently than others (94% versus 39%; Pϭ0.001), and 10 of them (63%) had a recurrence of PeAF. The recurrence rate of PeAF was significantly higher in those with an unsuccessful IRAF trigger ablation than in those with a successful IRAF trigger ablation (63% versus 11%; PϽ0.001). A multivariable analysis revealing the factors associated with the PeAF recurrence was performed. Binary variables with PϽ0.05 from univariate analysis ( Table 1) were included. We indicated that an unsuccessful IRAF trigger ablation, a longer sustained AF duration, and LA remodeling were independent predictors of a PeAF recurrence ( Table 2) .
Factors Associated With an Unsuccessful IRAF Trigger Ablation
We investigated factors associated with IRAF patients whose IRAF trigger ablation was unsuccessful. As shown in Table 3 , they had a longer AF persistent period (median, 36 versus 6 months; Pϭ0.042), a larger LA volume (87.5Ϯ27.6 versus 107.3Ϯ26.6 mL; Pϭ0.017), and a higher prevalence of multiple IRAF triggers (63% versus 15%; PϽ0.001) and those from non-PV origins (100% versus 13%; PϽ0.0001). All the IRAF triggers we failed to ablate were from non-PV, and the success rate of their ablation was low (6 [30%] of 23 patients) because it was difficult to locate their foci. We even had difficulty identifying the chamber that such triggers originated from in 4 (17%) of 23 patients. However, when non-PV IRAF triggers were ablated successfully, 6 (86%) of 7 patients maintained SR and the recurrence rate tended to be lower in patients with successful ablation of a non-PV IRAF trigger than those with an unsuccessful ablation (1 [14%] of 7 patients versus 10 [63%] of 16 patients; Pϭ0.09).
Discussion
In this article, we investigated the clinical significance of the IRAF triggers in the PeAF patients. An IRAF was observed in 27% of the patients. An IRAF was a risk factor for recurrent AF. In the PeAF patients, the ablation results were highly dependent on the success of the elimination of the IRAF triggers.
Ablation of the AF Substrate in the PeAF Patients
Ablation targeting the PVs is the most common approach, but PV ablation is often ineffective in patients with PeAF. This is because the AF substrate, the atrium, plays an important role in the mechanism of AF persistence and PV isolation alone is not adequate to eliminate the perpetuators. Thus, in addition to PV isolation, extensive substrate modification, such as linear ablation, 3 and ablation of the high-frequency atrial activity with the intent of terminating the AF are often performed. 1, 2 The practitioners using those approaches do not investigate the arrhythmogenicity, and the role of the triggers in the PeAF patients falls to a minor role. However, we believe the triggers also play an important role in the mechanism of the AF persistence, because their presence may provide a greater chance of reinitiating AF, even in patients with PeAF. We previously reported that multiple triggers were likely to be involved in the development of AF persistence. 9 In addition to the multiplicity of the AF triggers, the activity of the AF triggers might also have a great impact on the persistence.
Hypothesis About the Mechanism of AF Persistence and IRAF
It is thought that "triggers" are important for the initiation of AF, whereas "substrates" are necessary for the maintenance of PeAF, and paroxysmal AF progresses to PeAF because of the progression of the AF substrate that initiates more AF persistency ( Figure 1A) . In such a situation, the duration of the paroxysmal AF becomes longer as the AF substrate progresses, and the AF finally no longer terminates, and persists ( Figure 1B ). However, it is possible that there is a trigger-based mechanism of AF persistence; the activity of the AF triggers is so elevated that AF is initiated frequently, and a "new" AF occurs before the "old" Data are given as meanϮSD unless otherwise indicated. We defined long-lasting persistent AF as AF persisting Ͼ1 y, and remodeling of LA as LA volume Ͼ100 mL. AAD indicates antiarrhythmic drugs; AFCL, AF cycle length; BNP, brain natriuretic peptide; CHF, congestive heart failure; eGFR, estimated glomerular filtration rate; IQR, interquartile range (25%-75%); IRAF trigger, premature atrial contraction that triggers an IRAF; LVEF, left ventricular ejection fraction; RA, right atrium; SHD, structural heart disease. one terminates and, as a result, AF persists ( Figure 1C ). If the PeAF patients with this trigger-based mechanism of AF persistence received electric cardioversion, AF would recur immediately ( Figure 1D ). This is exactly the phenomenon called an IRAF 4, 5 (Table 2) . Thus, the patients with an IRAF should have this mechanism of AF persistence and IRAF triggers would play an essential role in the pathophysiological characteristics of the PeAF in these patients. In these patients, an ablation strategy targeting such triggers might be preferable.
Characteristics of Patients With an IRAF
In this study population, an IRAF was observed in as much as 27% of the PeAF patients. The patients with an IRAF background were similar to those without it, with the exception of the prevalence of hypertension. Thus, it is difficult to determine the presence or absence of an IRAF based on the patient characteristics.
Presence of an IRAF Affects the Efficacy of the PeAF Ablation
In this study, more patients with PeAF recurrences had IRAFs than did those who stayed in SR (Table 1) , and we wanted to determine the reason for the poorer results of the PeAF ablation in the patients with an IRAF than in those without an IRAF, despite similar baseline characteristics. A multivariable regression analysis revealed that an unsuccessful ablation of the IRAF triggers was 1 of the independent risk factors of PeAF recurrence ( Table 2 ). On the other hand, the efficacy of the CA in PeAF patients with a successful IRAF trigger ablation was relatively good and almost equivalent to that of those without an IRAF. These data would indicate that the presence of the remaining IRAF triggers after ablation, not the presence of an IRAF itself, was the reason for the poorer ablation efficacy in the IRAF patients. Thus, in the IRAF patients, the IRAF triggers play an important role in the pathophysiological characteristics of the PeAF; the success of the CA of PeAF is highly dependent on the successful elimination of the IRAF triggers. These results support our hypothesis on the trigger-based mechanism of AF persistence previously described.
Ablation of the Targeted PeAF Triggers
Our data indicated the importance of the investigation and ablation of arrhythmogenic foci, even in the PeAF patients. Haisaguerre et al reported that catheter ablation of chronic AF targeting the PV triggers reinitiating AF was partially effective. 10 Dixit et al demonstrated that the isolation of arrhythmogenic PVs was as effective as an empirical isolation of all veins in achieving control of the AF, including persistent AF. 11 Their reports also suggested that ablation targeting AF triggers is sufficiently effective to control PeAF in some patients.
Unsuccessful IRAF Trigger Ablation and Their Origin
An unsuccessful IRAF trigger ablation was greatly associated with their origin (Table 3) ; thus, there was a great possibility that the non-PV trigger itself, not an unsuccessful trigger ablation, affected the results of the ablation. However, we also found that most patients with a successful ablation of non-PV IRAF triggers maintained SR. These data suggested that the elimination of such triggers, not the origin of the IRAF trigger, affected the result of the ablation.
Clinical Implications
Approximately one fourth of the PeAF patients had an IRAF. We tried to eliminate an IRAF trigger in addition to PV isolation and found that the clinical outcome of the AF ablation was strongly influenced by the success of the elimination of the IRAF triggers. In the patients in whom the elimination of the IRAF triggers failed, SR could not be maintained in most of them, even though extensive substrate modification of the atria was performed. Thus, investigating the presence or absence of an IRAF and the origin of the IRAF triggers is useful for deciding the strategy of ablation; PV isolation and IRAF trigger ablation might improve the outcome and avoid unnecessary ablation of the atria in PeAF patients with an IRAF. Data are given as meanϮSD unless otherwise indicated. AFCL indicates AF cycle length; BNP, brain natriuretic peptide; CHF, congestive heart failure; IQR, interquartile range (25%-75%); IRAF triggers, premature atrial contraction that triggers an IRAF; RA, right atrium; SHD, structural heart disease.
Study Limitations
We defined an IRAF as the reproducible recurrence of AF within 90 s after the restoration of SR by cardioversion. However, we did not know whether 90 s was the best observational time period. Our data lend support to the hypothesis of a trigger-based AF persistence mechanism but are not a direct demonstration of it because we also performed the elimination of PV substrate by the PV isolation in all patients and the LA substrate modification in some patients. The difference in the use of CFAE and lines could also have influenced recurrence. If focal ablation of IRAF triggers is adequate to maintain SR in some of the IRAF patients, our hypothesis would be directly demonstrated. However, such a protocol involves some ethical problems. To make the end point clear, the recurrence of PeAF was based on the 12-lead ECG at the most recent hospital visit, because it is often difficult to determine the presence or absence of residual paroxysmal attacks. Then, some patients with the recurrence of paroxysmal AF might belong to the SR group. Because the result of the IRAF trigger ablation is highly correlated with the result of AF ablation, the investigation elucidating the factors associated with success of IRAF trigger ablation is valuable. Then, we performed univariate analyses in Table 3 . However, this analysis was performed on a small sample of patients and we cannot exclude the possibility of type 1 and type 2 errors. Thus, this analysis might be exploratory.
Conclusions
The failure of the elimination of PACs initiating IRAF was significantly associated with the recurrence of PeAF. Thus, we should adopt a strategy targeting the IRAF triggers in addition to PV isolation. These results also imply that the triggers play a major role in the AF persistence in some PeAF patients.
